Incyte to Present at Upcoming Investor Conferences
WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte Corporation (INCY) announced today it will present at the following investor conferences during the month of September:
- Robert W. Baird & Co. 2012 Health Care Conference on Wednesday, September 5, 2012 at 10:10 a.m. (ET) in New York City;
- Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2012 at 10:55 a.m. (ET) in New York City;
- ThinkEquitys 9th Annual Growth Conference on Thursday, September 13, 2012 at 1:30 p.m. (ET) in New York City; and
- UBS Global Life Sciences Conference on Thursday, September 20, 2012 at 1:00 p.m. (ET) in New York City
The presentations will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentations will be available. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at www.incyte.com.
Pamela M. Murphy
Vice President, Investor Relations/Corporate Communications
Source: Incyte CorporationCopyright Business Wire 2012